Glioblastoma (GBM) is the most common primary intracranial malignant tumor. Recent
literature suggests that induction of programmed death has become a mainstream cancer …

Abstract HOXC cluster antisense RNA 3 (HOXC-AS3) is a novel long noncoding RNA
(lncRNA) that exhibits aberrant expression patterns in various cancer types. Its expression is …

Improving clinical immunotherapy for glioblastoma (GBM) relies on addressing the
immunosuppressive tumor microenvironment (TME). Enhancing CD8+ T cell infiltration and …

Purpose Brain tumors, particularly glioblastoma multiforme (GBM), present significant
prognostic challenges despite multimodal therapies, including surgical resection …

Background LncRNAs regulate tumorigenesis and development in a variety of cancers. We
substantiate for the first time that LINC00606 is considerably expressed in glioblastoma …

Background: Exercise has been shown to improve quality of life (QoL) and even treatment
outcomes in cancer patients. However, the evidence to support the benefits of exercise in …

Vasculogenic mimicry (VM), which involved the formation of vascular-like structures by
highly invasive tumor cells, had been identified as one of the mechanisms contributing to …

Purpose Glioblastoma is an aggressive brain tumor with high mortality and a median
survival of about 15 months. Starting from our previous published compound, MV1035 that …

Glioma is the most common malignant intracranial tumor, accounting for 80% of all
malignant brain tumors. Growing evidence suggests that lncRNAs are involved in the …

Backgrounds The overall survival of patients with lower-grade gliomas and glioblastoma
varies greatly. No reliable or existing procedures can accurately forecast survival and …